Please upgrade your browser.
The Kidney Cancer Friends Facebook Group is a forum for open discussion of kidney cancer (subject to whatever limitations Facebook chooses to impose).
"Prognosis is an estimate of the likely outcome,or course, of a disease."
Star Career Academy students from the school's Long Island campus, will honor classmate Megan Reister, who had a failed kidney transplant at the age of 15 and family members who have survived kidney cancer...
Now in 6 late-stage studies, the treatment (BMS-936558 acquired in the Medarex buyout) spurred tumor shrinkage in three of 5 cancer groups studied, including 18% of 72 lung cancer patients, close to a third of 98 melanoma patients and 27% of 33 patients with kidney cancer.
"This joint venture brings us one step closer to providing Chinese patients with Amgen's medicines and supports our strategy of expanding in key, fast-growing markets," said Anthony Hooper, executive vice president at Amgen.
Here's a sneak peek at something new we're launching later this month. It's a collaboration that will enable patients to help transform medicine in ways that could help researchers to speed new treatments from the bench to the bedside. Stay tuned!
Jennerex, Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced that the United States Food and Drug Administration (FDA) granted orphan drug designation for Pexa-Vec (JX-594, pexastimogene devacirepvec) for the treatment of hepatocellular carcinoma (HCC, commonly referred to as liver cancer).
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announces that the Company's miRview® suite of oncology diagnostic assays will be highlighted in an "Industry Expert Theater Presentation" at the American Society of Clinical Oncologists (ASCO) 2013 Annual Meeting taking place from May 31-June 4 at McCormick Place Convention Center in Chicago.
Cholesterol-lowering statin drugs that are taken by millions of Americans might also improve survival from a type of kidney cancer called renal cell carcinoma, a new study suggests.
Robot-assisted surgery to remove kidney cancers has seen a rapid increase in use, and has both replaced and proven safer than laparoscopic procedures for the same purpose, according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit.
|Powered by NeonCRM|